Insulinoma Treatment Market – Size, Share and Forecast (2019-2026)
SKU: DPC277 | Last Updated On: Jul 15 2019 | No. of Pages: 221 | Available Formats 
Insulinoma Treatment Market – Size, Share and Forecast (2019-2026)
SKU: DPC277 | Published On: Jul 15 2019 | No. of Pages: 221 | Available Formats
1.Global Insulinoma Treatment Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Global Insulinoma Treatment Market – Market Definition and Overview
3. Global Insulinoma Treatment Market – Executive Summary
3.1. Market Snippet by Treatment Type
3.2. Market Snippet by Region
3.3. DataM CLO Scenario
4. Global Insulinoma Treatment Market – Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising prevalence of neuroendocrine pancreatic tumors
4.1.1.2. Technological advancements
4.1.1.3. Favorable government policies
4.1.2. Restraints
4.1.2.1. High cost of treatment
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Global Insulinoma Treatment Market – Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Epidemiology
6. Global Insulinoma Treatment Market – By Treatment Type
6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
6.3. Market Attractiveness Index, By Treatment Type
6.4. Surgery
6.4.1. Introduction
6.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
6.5. Radiofrequency Ablation
6.6. Cryotherapy
6.7. Chemotherapy
7. Global Insulinoma Treatment Market – By Region
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
7.3. Market Attractiveness Index, By Region
7.4. North America
7.4.1. Introduction
7.4.2. Key Region-Specific Dynamics
7.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
7.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
7.4.4.1. U.S.
7.4.4.2. Canada
7.4.4.3. Mexico
7.5. Europe
7.5.1. Introduction
7.5.2. Key Region-Specific Dynamics
7.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
7.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
7.5.4.1. Germany
7.5.4.2. U.K.
7.5.4.3. France
7.5.4.4. Italy
7.5.4.5. Spain
7.5.4.6. Rest of Europe
7.6. South America
7.6.1. Introduction
7.6.2. Key Region-Specific Dynamics
7.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
7.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
7.6.4.1. Brazil
7.6.4.2. Argentina
7.6.4.3. Rest of South America
7.7. Asia-Pacific
7.7.1. Introduction
7.7.2. Key Region-Specific Dynamics
7.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
7.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
7.7.4.1. China
7.7.4.2. India
7.7.4.3. Japan
7.7.4.4. Australia
7.7.4.5. Rest of Asia Pacific
7.8. Middle East and Africa
7.8.1. Introduction
7.8.2. Key Region-Specific Dynamics
7.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
8. Global Market – Competitive Landscape
8.1. Competitive Scenario
8.2. Competitor Insulinoma Treatment Strategy Analysis
8.3. Comparative Product Portfolio Analysis
8.4. Market Positioning/Share Analysis
8.5. Mergers and Acquisitions Analysis
9. Company Profiles
9.1. Ipsen Pharma *
9.1.1. Company Overview
9.1.2. Product Portfolio and Description
9.1.3. Key Highlights
9.1.4. Financial Overview
9.2. Johnson & Johnson
9.3. Novartis
9.4. Pfizer
9.5. Teva Pharmaceutical Industries
9.6. Abcam plc
9.7. Cironpharma
9.8. Entax Medical
9.9. Olympus
9.10. Boston Scientific Corporation
9.11. Medtronic
9.12. Cook Medical
10. Global Insulinoma Treatment Market – Premium Insights
11. Global Insulinoma Treatment Market – DataM
11.1. Appendix
11.2. About Us and Services
11.3. Contact Us
Guide this sample report to your Inbox
Please fill in all the fields below.
Note: Your privacy is important to us. Any information you provide to us is stored on our secure servers.
List of Tables
Table 1 Global Insulinoma Treatment Market Value, By Treatment Type, 2018,2022 & 2026 ($ Million)
Table 2 Global Insulinoma Treatment Market Value, By Region, 2018,2022 & 2026 ($ Million)
Table 3 Global Insulinoma Treatment Market Value, By Treatment Type, 2018,2022 & 2026 ($ Million)
Table 4 Global Insulinoma Treatment Market Value, By Treatment Type, 2017-2026 ($ Million)
Table 5 Global Insulinoma Treatment Market Value, By Region, 2018,2022 & 2026 ($ Million)
Table 6 Global Insulinoma Treatment Market Value, By Region, 2017-2026 ($ Million)
Table 7 North America Insulinoma Treatment Market Value, By Treatment Type, 2017-2026 ($ Million)
Table 8 North America Insulinoma Treatment Market Value, By Country, 2017-2026 ($ Million)
Table 9 South America Insulinoma Treatment Market Value, By Treatment Type, 2017-2026 ($ Million)
Table 10 South America Insulinoma Treatment Market Value, By Country, 2017-2026 ($ Million)
Table 11 Europe Insulinoma Treatment Market Value, By Treatment Type, 2017-2026 ($ Million)
Table 12 Europe Insulinoma Treatment Market Value, By Country, 2017-2026 ($ Million)
Table 13 Asia-Pacific Insulinoma Treatment Market Value, By Treatment Type, 2017-2026 ($ Million)
Table 14 Asia-Pacific Insulinoma Treatment Market Value, By Country, 2017-2026 ($ Million)
Table 15 Middle East & Africa Insulinoma Treatment Market Value, By Treatment Type, 2017-2026 ($ Million)
Table 16 Ipsen Pharma: Overview
Table 17 Ipsen Pharma: Product Portfolio
Table 18 Ipsen Pharma: Key Developments
Table 19 Johnson & Johnson: Overview
Table 20 Johnson & Johnson: Product Portfolio
Table 21 Johnson & Johnson: Key Developments
Table 22 Novartis: Overview
Table 23 Novartis: Product Portfolio
Table 24 Novartis: Key Developments
Table 25 Pfizer: Overview
Table 26 Pfizer: Product Portfolio
Table 27 Pfizer: Key Developments
Table 28 Teva Pharmaceutical Industries: Overview
Table 29 Teva Pharmaceutical Industries: Product Portfolio
Table 30 Teva Pharmaceutical Industries: Key Developments
Table 31 Abcam plc: Overview
Table 32 Abcam plc: Product Portfolio
Table 33 Abcam plc: Key Developments
Table 34 Cironpharma: Overview
Table 35 Cironpharma: Product Portfolio
Table 36 Cironpharma: Key Developments
Table 37 Entax Medical: Overview
Table 38 Entax Medical: Product Portfolio
Table 39 Entax Medical: Key Developments
Table 40 Olympus: Overview
Table 41 Olympus: Product Portfolio
Table 42 Olympus: Key Developments
Table 43 Boston Scientific Corporation: Overview
Table 44 Boston Scientific Corporation: Product Portfolio
Table 45 Boston Scientific Corporation: Key Developments
List of Figures
Figure 1 Global Insulinoma Treatment Market Share, By Treatment Type, 2018 & 2026 (%)
Figure 2 Global Insulinoma Treatment Market Share, By Region, 2018 & 2026 (%)
Figure 3 Global Insulinoma Treatment Market Value, 2017-2026 ($ Million)
Figure 4 Global Insulinoma Treatment Market Y-o-Y Growth, By Treatment Type, 2018-2026 (%)
Figure 5 Surgery: Global Insulinoma Treatment Market Value, 2017-2026 ($ Million)
Figure 6 Radiofrequency Ablation: Global Insulinoma Treatment Market Value, 2017-2026 ($ Million)
Figure 7 Cryotherapy: Global Insulinoma Treatment Market Value, 2017-2026 ($ Million)
Figure 8 Chemotherapy: Global Insulinoma Treatment Market Value, 2017-2026 ($ Million)
Figure 9 Global Insulinoma Treatment Market Y-o-Y Growth, By Region, 2018-2026 (%)
Figure 10 North America Insulinoma Treatment Market Value, 2017-2026 ($ Million)
Figure 11 North America Insulinoma Treatment Market Share, By Treatment Type, 2018 & 2026 (%)
Figure 12 North America Insulinoma Treatment Market Share, By Country, 2018 & 2026 (%)
Figure 13 South America Insulinoma Treatment Market Value, 2017-2026 ($ Million)
Figure 14 South America Insulinoma Treatment Market Share, By Treatment Type, 2018 & 2026 (%)
Figure 15 South America Insulinoma Treatment Market Share, By Country, 2018 & 2026 (%)
Figure 16 Europe Insulinoma Treatment Market Value, 2017-2026 ($ Million)
Figure 17 Europe Insulinoma Treatment Market Share, By Treatment Type, 2018 & 2026 (%)
Figure 18 Europe Insulinoma Treatment Market Share, By Country, 2018 & 2026 (%)
Figure 19 Asia-Pacific Insulinoma Treatment Market Value, 2017-2026 ($ Million)
Figure 20 Asia-Pacific Insulinoma Treatment Market Share, By Treatment Type, 2018 & 2026 (%)
Figure 21 Asia-Pacific Insulinoma Treatment Market Share, By Country, 2018 & 2026 (%)
Figure 22 Middle East & Africa Insulinoma Treatment Market Value, 2017-2026 ($ Million)
Figure 23 Middle East & Africa Insulinoma Treatment Market Share, By Treatment Type, 2018 & 2026 (%)
Figure 24 Ipsen Pharma: Financials
Figure 25 Johnson & Johnson: Financials
Figure 26 Novartis: Financials
Figure 27 Pfizer: Financials
Figure 28 Teva Pharmaceutical Industries: Financials
Figure 29 Abcam plc: Financials
Figure 30 Cironpharma: Financials
Figure 31 Entax Medical: Financials
Figure 32 Olympus: Financials
Figure 33 Boston Scientific Corporation: Financials
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!